13 days ago
A
AnalystsDaniel AriasDaniel Arias's Stock Forecasts
AnalystsDaniel Arias
Analyst Ranking
Top 12%
#637 out of 5507 analysts
Average Return
+15.01%
Win Rate
53%51 out of 96
Risk vs Reward
Poor
Good
Daniel Arias's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
10x Genomics IncTXG | +262.03% | $18.12 | $65.60 | 2026-02-13 - 2026-09-08 | Strong Buy |
Nanostring Technologies IncNSTGQ | +198.16% | $22.86 | $68.16 | 2020-04-02 - 2021-04-01 | Strong Buy |
10x Genomics IncTXG | +183.49% | $23.14 | $65.60 | 2026-03-02 - 2026-09-08 | Strong Buy |
Guardant Health IncGH | +167.50% | $60.18 | $160.98 | 2025-09-25 - 2026-09-08 | Strong Buy |
908 Devices IncMASS | +152.14% | $2.34 | $5.90 | 2024-11-13 - 2025-11-12 | Strong Buy |
Daniel Arias Analyst Color
Get additional color on Daniel Arias's coverage of popular stocks
a month ago
MASS
a month ago
ALMR
a month ago
GH
8 months ago
TMO
8 months ago
GH
10 months ago
EXAS
a year ago
GH
2 years ago
GH
2 years ago
TMO
2 years ago
AVTR
2 years ago
TMO
3 years ago
RGEN
3 years ago
TXG
Daniel Arias's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Agilent Technologies IncA | 14 | Strong Buy | $180.00 | +22.57% | Maintains | 13 days ago |
908 Devices IncMASS | 3 | Strong Buy | $12.00 | +22.32% | Maintains | a month ago |
Alamar Biosciences IncALMR | 2 | Strong Buy | $32.00 | +6.84% | Maintains | a month ago |
Tempus Ai IncTEM | 3 | Hold | $50.00 | -22.23% | Maintains | a month ago |
Mettler Toledo International IncMTD | 9 | Strong Buy | $1,600.00 | +20.71% | Maintains | a month ago |
Guardant Health IncGH | 7 | Strong Buy | $180.00 | +11.82% | Maintains | a month ago |
Illumina IncILMN | 13 | Strong Buy | $225.00 | +6.60% | Maintains | a month ago |
Avantor IncAVTR | 8 | Hold | $15.00 | -1.64% | Maintains | a month ago |
Danaher CorpDHR | 7 | Strong Buy | $220.00 | +7.20% | Maintains | 2 months ago |
Aib Data Centers IncAIB | 1 | Strong Buy | $6.75 | +372.03% | Initiates Coverage On | 2 months ago |
Qiagen NvQGEN | 5 | Hold | $36.00 | -15.05% | Maintains | 4 months ago |
Revvity IncRVTY | 5 | Hold | $100.00 | -21.31% | Maintains | 4 months ago |
Thermo Fisher Scientific IncTMO | 14 | Strong Buy | $600.00 | -0.50% | Maintains | 5 months ago |
10x Genomics IncTXG | 8 | Strong Buy | $25.00 | -61.89% | Maintains | 6 months ago |
Bio Techne CorpTECH | 12 | Hold | $65.00 | -10.11% | Maintains | 7 months ago |
Billiontoone IncBLLN | 1 | Strong Buy | $145.00 | +46.38% | Initiates Coverage On | 9 months ago |
Exact Sciences CorpEXAS | 7 | Hold | $105.00 | -94.37% | Downgrades | 9 months ago |
Bruker CorpBRKR | 7 | Hold | $40.00 | N/A | Maintains | a year ago |
Maxcyte IncMXCT | 2 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
Waters CorpWAT | 11 | Hold | $360.00 | N/A | Maintains | 2 years ago |
Maravai Lifesciences Holdings IncMRVI | 2 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Repligen CorpRGEN | 6 | Strong Buy | $207.00 | N/A | Maintains | 3 years ago |
Codexis IncCDXS | 2 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Phenomex IncCELL | 3 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Somalogic IncSLGC | 2 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Renalytix PLCRNLXY | 2 | Strong Buy | $7.00 | N/A | Maintains | 4 years ago |
Absci CorpABSI | 2 | Hold | $10.00 | N/A | Maintains | 4 years ago |
Nanostring Technologies IncNSTGQ | 1 | Strong Buy | $35.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.